nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycopyrrolate—CHRM4—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0231	0.027	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0221	0.0259	CbGpPWpGaD
Glycopyrrolate—CHRM4—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0197	0.0231	CbGpPWpGaD
Glycopyrrolate—CHRM4—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0191	0.0224	CbGpPWpGaD
Glycopyrrolate—CHRM5—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0189	0.0221	CbGpPWpGaD
Glycopyrrolate—CHRM5—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0183	0.0214	CbGpPWpGaD
Glycopyrrolate—CHRM4—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0178	0.0209	CbGpPWpGaD
Glycopyrrolate—CHRM5—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0171	0.02	CbGpPWpGaD
Glycopyrrolate—CHRM4—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0166	0.0194	CbGpPWpGaD
Glycopyrrolate—CHRM4—nervous system—Gilles de la Tourette syndrome	0.0164	0.113	CbGeAlD
Glycopyrrolate—CHRM4—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0161	0.0188	CbGpPWpGaD
Glycopyrrolate—CHRM5—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0159	0.0186	CbGpPWpGaD
Glycopyrrolate—CHRM4—central nervous system—Gilles de la Tourette syndrome	0.0158	0.109	CbGeAlD
Glycopyrrolate—CHRM1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0156	0.0182	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0155	0.0182	CbGpPWpGaD
Glycopyrrolate—CHRM5—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0154	0.018	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0154	0.018	CbGpPWpGaD
Glycopyrrolate—CHRM4—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.015	0.0175	CbGpPWpGaD
Glycopyrrolate—CHRM5—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0144	0.0168	CbGpPWpGaD
Glycopyrrolate—CHRM1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0133	0.0156	CbGpPWpGaD
Glycopyrrolate—CHRM3—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0133	0.0155	CbGpPWpGaD
Glycopyrrolate—CHRM2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0131	0.0154	CbGpPWpGaD
Glycopyrrolate—CHRM1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0129	0.0151	CbGpPWpGaD
Glycopyrrolate—CHRM3—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0129	0.0151	CbGpPWpGaD
Glycopyrrolate—CHRM5—nervous system—Gilles de la Tourette syndrome	0.0128	0.0884	CbGeAlD
Glycopyrrolate—CHRM2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0127	0.0149	CbGpPWpGaD
Glycopyrrolate—CHRM4—brain—Gilles de la Tourette syndrome	0.0126	0.0864	CbGeAlD
Glycopyrrolate—CHRM4—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0125	0.0146	CbGpPWpGaD
Glycopyrrolate—CHRM5—central nervous system—Gilles de la Tourette syndrome	0.0124	0.0851	CbGeAlD
Glycopyrrolate—CHRM1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.012	0.0141	CbGpPWpGaD
Glycopyrrolate—CHRM3—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.012	0.014	CbGpPWpGaD
Glycopyrrolate—CHRM5—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.012	0.014	CbGpPWpGaD
Glycopyrrolate—CHRM2—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0119	0.0139	CbGpPWpGaD
Glycopyrrolate—CHRM1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0112	0.0131	CbGpPWpGaD
Glycopyrrolate—CHRM3—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0111	0.013	CbGpPWpGaD
Glycopyrrolate—CHRM2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.011	0.0129	CbGpPWpGaD
Glycopyrrolate—CHRM1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0108	0.0127	CbGpPWpGaD
Glycopyrrolate—CHRM3—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0108	0.0127	CbGpPWpGaD
Glycopyrrolate—CHRM2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0107	0.0125	CbGpPWpGaD
Glycopyrrolate—CHRM4—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0105	0.0123	CbGpPWpGaD
Glycopyrrolate—CHRM1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0101	0.0118	CbGpPWpGaD
Glycopyrrolate—CHRM3—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0101	0.0118	CbGpPWpGaD
Glycopyrrolate—CHRM5—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0101	0.0118	CbGpPWpGaD
Glycopyrrolate—CHRM2—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.00998	0.0117	CbGpPWpGaD
Glycopyrrolate—CHRM5—brain—Gilles de la Tourette syndrome	0.00982	0.0675	CbGeAlD
Glycopyrrolate—CHRM2—nervous system—Gilles de la Tourette syndrome	0.00882	0.0607	CbGeAlD
Glycopyrrolate—CHRM2—central nervous system—Gilles de la Tourette syndrome	0.00849	0.0584	CbGeAlD
Glycopyrrolate—CHRM1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00842	0.00985	CbGpPWpGaD
Glycopyrrolate—CHRM3—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00839	0.00982	CbGpPWpGaD
Glycopyrrolate—CHRM2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.00831	0.00973	CbGpPWpGaD
Glycopyrrolate—CHRM1—nervous system—Gilles de la Tourette syndrome	0.00803	0.0552	CbGeAlD
Glycopyrrolate—CHRM1—central nervous system—Gilles de la Tourette syndrome	0.00773	0.0532	CbGeAlD
Glycopyrrolate—CHRM3—nervous system—Gilles de la Tourette syndrome	0.00718	0.0494	CbGeAlD
Glycopyrrolate—CHRM1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00708	0.00828	CbGpPWpGaD
Glycopyrrolate—CHRM3—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00706	0.00826	CbGpPWpGaD
Glycopyrrolate—CHRM2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.00699	0.00818	CbGpPWpGaD
Glycopyrrolate—CHRM3—central nervous system—Gilles de la Tourette syndrome	0.00691	0.0476	CbGeAlD
Glycopyrrolate—CHRM2—brain—Gilles de la Tourette syndrome	0.00674	0.0464	CbGeAlD
Glycopyrrolate—CHRM1—brain—Gilles de la Tourette syndrome	0.00613	0.0422	CbGeAlD
Glycopyrrolate—CHRM3—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00589	0.00689	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.00583	0.00682	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00571	0.00669	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.00566	0.00662	CbGpPWpGaD
Glycopyrrolate—CHRM3—brain—Gilles de la Tourette syndrome	0.00549	0.0378	CbGeAlD
Glycopyrrolate—CHRM4—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.0041	0.0048	CbGpPWpGaD
Glycopyrrolate—CHRM4—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00398	0.00466	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.0038	0.00445	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00373	0.00436	CbGpPWpGaD
Glycopyrrolate—CHRM4—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00371	0.00434	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00369	0.00432	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.00369	0.00432	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00364	0.00426	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00354	0.00414	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00344	0.00403	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.0033	0.00386	CbGpPWpGaD
Glycopyrrolate—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00326	0.00381	CbGpPWpGaD
Glycopyrrolate—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00316	0.0037	CbGpPWpGaD
Glycopyrrolate—CHRM1—Circadian rythm related genes—DRD3—Gilles de la Tourette syndrome	0.00313	0.00367	CbGpPWpGaD
Glycopyrrolate—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00312	0.00365	CbGpPWpGaD
Glycopyrrolate—CHRM1—Circadian rythm related genes—DRD4—Gilles de la Tourette syndrome	0.00304	0.00356	CbGpPWpGaD
Glycopyrrolate—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00303	0.00355	CbGpPWpGaD
Glycopyrrolate—CHRM5—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.00299	0.00349	CbGpPWpGaD
Glycopyrrolate—CHRM4—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00295	0.00345	CbGpPWpGaD
Glycopyrrolate—CHRM1—Circadian rythm related genes—DRD2—Gilles de la Tourette syndrome	0.00283	0.00331	CbGpPWpGaD
Glycopyrrolate—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00282	0.0033	CbGpPWpGaD
Glycopyrrolate—CHRM2—G alpha (i) signalling events—DRD3—Gilles de la Tourette syndrome	0.00273	0.00319	CbGpPWpGaD
Glycopyrrolate—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00267	0.00312	CbGpPWpGaD
Glycopyrrolate—CHRM2—G alpha (i) signalling events—DRD4—Gilles de la Tourette syndrome	0.00265	0.0031	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00257	0.003	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00256	0.00299	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00253	0.00296	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00249	0.00291	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00248	0.0029	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00248	0.0029	CbGpPWpGaD
Glycopyrrolate—CHRM2—G alpha (i) signalling events—DRD2—Gilles de la Tourette syndrome	0.00247	0.00289	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00246	0.00288	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00241	0.00282	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00241	0.00282	CbGpPWpGaD
Glycopyrrolate—CHRM2—SIDS Susceptibility Pathways—HTR2A—Gilles de la Tourette syndrome	0.0024	0.00281	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00238	0.00278	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00232	0.00271	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00231	0.00271	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00231	0.0027	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00231	0.0027	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00229	0.00268	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00224	0.00263	CbGpPWpGaD
Glycopyrrolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.0022	0.00257	CbGpPWpGaD
Glycopyrrolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00219	0.00256	CbGpPWpGaD
Glycopyrrolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00217	0.00254	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00215	0.00252	CbGpPWpGaD
Glycopyrrolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00213	0.0025	CbGpPWpGaD
Glycopyrrolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00213	0.00249	CbGpPWpGaD
Glycopyrrolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00211	0.00246	CbGpPWpGaD
Glycopyrrolate—CHRM1—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.0021	0.00246	CbGpPWpGaD
Glycopyrrolate—CHRM3—G alpha (q) signalling events—HTR2A—Gilles de la Tourette syndrome	0.0021	0.00245	CbGpPWpGaD
Glycopyrrolate—CHRM4—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00206	0.00242	CbGpPWpGaD
Glycopyrrolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00199	0.00233	CbGpPWpGaD
Glycopyrrolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00198	0.00232	CbGpPWpGaD
Glycopyrrolate—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00198	0.00231	CbGpPWpGaD
Glycopyrrolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00196	0.0023	CbGpPWpGaD
Glycopyrrolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00188	0.0022	CbGpPWpGaD
Glycopyrrolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	0.00187	0.00219	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00167	0.00196	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00167	0.00195	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00165	0.00193	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00162	0.0019	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00162	0.0019	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00162	0.0019	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00162	0.0019	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.0016	0.00188	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.0016	0.00188	CbGpPWpGaD
Glycopyrrolate—CHRM3—Metabolism—HDC—Gilles de la Tourette syndrome	0.0016	0.00187	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00157	0.00184	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00151	0.00177	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00151	0.00177	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00151	0.00176	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00149	0.00175	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.0014	0.00164	CbGpPWpGaD
Glycopyrrolate—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00139	0.00163	CbGpPWpGaD
Glycopyrrolate—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00139	0.00162	CbGpPWpGaD
Glycopyrrolate—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00137	0.00161	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00136	0.00159	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00134	0.00157	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.0013	0.00153	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00127	0.00149	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00127	0.00148	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00124	0.00145	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00122	0.00143	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00121	0.00142	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00118	0.00139	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00115	0.00135	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.0011	0.00129	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00106	0.00124	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00106	0.00124	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00105	0.00122	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000946	0.00111	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000943	0.0011	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.000934	0.00109	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000918	0.00107	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000915	0.00107	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.000906	0.00106	CbGpPWpGaD
Glycopyrrolate—CHRM4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000889	0.00104	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000859	0.00101	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000856	0.001	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000855	0.001	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000853	0.000998	CbGpPWpGaD
Glycopyrrolate—CHRM5—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000851	0.000996	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.000848	0.000992	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.000844	0.000988	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000834	0.000976	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000831	0.000973	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.000823	0.000963	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000807	0.000944	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000777	0.000909	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000774	0.000906	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000773	0.000904	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.000767	0.000897	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000753	0.000881	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000731	0.000855	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000721	0.000843	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.0007	0.000819	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000681	0.000796	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000652	0.000763	CbGpPWpGaD
Glycopyrrolate—CHRM1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000599	0.000701	CbGpPWpGaD
Glycopyrrolate—CHRM3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000597	0.000699	CbGpPWpGaD
Glycopyrrolate—CHRM2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.000591	0.000692	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000544	0.000637	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000542	0.000635	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.000537	0.000628	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000507	0.000594	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000506	0.000592	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.000501	0.000586	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000493	0.000576	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000491	0.000575	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.000486	0.000569	CbGpPWpGaD
Glycopyrrolate—CHRM4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000477	0.000558	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000459	0.000537	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000457	0.000535	CbGpPWpGaD
Glycopyrrolate—CHRM5—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000456	0.000534	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.000453	0.00053	CbGpPWpGaD
Glycopyrrolate—CHRM1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000321	0.000376	CbGpPWpGaD
Glycopyrrolate—CHRM3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00032	0.000375	CbGpPWpGaD
Glycopyrrolate—CHRM2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.000317	0.000371	CbGpPWpGaD
